Ming Zhou

6.0k total citations · 1 hit paper
61 papers, 4.2k citations indexed

About

Ming Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ming Zhou has authored 61 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 28 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Ming Zhou's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (13 papers). Ming Zhou is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (13 papers). Ming Zhou collaborates with scholars based in China, United States and Saudi Arabia. Ming Zhou's co-authors include Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bo Xiang, Xiaoling Li, Can Guo, Yong Li, Jie Wang, Junshang Ge and Jian Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Zhou

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

2019 1.1k citations Xianjie Jiang, Jie Wang et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Ming Zhou

Since Specialization

Citations

This map shows the geographic impact of Ming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhou more than expected).

Fields of papers citing papers by Ming Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhou. The network helps show where Ming Zhou may publish in the future.

Co-authorship network of co-authors of Ming Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhou. A scholar is included among the top collaborators of Ming Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhou. Ming Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding the role of C5a/C5aR1-mediated complement activation pathway in tumor progression and therapy resistance 2025 ·Science China Life Sciences ·(unknown), (unknown), Mengna Li, (unknown), (unknown), (unknown), Xiaolong Li, Ting Zeng, (unknown), Wei Xiong, (unknown), Ming Zhou	0
2	Hypoxic Cancer Cells‐Derived Exosomes Strengthen the Development of Cancer Stem Cell‐Like Properties Through Delivering LINC00665 in Thyroid Cancer Cells 2025 ·Cell Biology International ·Ming Zhou, (unknown), Qiong Zhang, (unknown)	2
3	Solvent‐Mediated Charge Transfer Regulation of Inner Core Clusters in Hybrid Copper(I)‐Based Halides for High‐Efficiency X‐Ray Scintillation 2025 ·Angewandte Chemie ·Wen‐Kui Dong, Fan Yang, Siyuan Zhang, (unknown), Ming Zhou, Huifang Li, Dianxing Ju	0
4	Predictive factors for persistent postoperative hydrocephalus in children undergoing surgical resection of periventricular tumors 2023 ·Frontiers in Neurology ·(unknown), Ming Zhou, (unknown), Qiang Wang, (unknown), Yuan Zhang, Wangming Zhang	3
5	Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1 2021 ·Cancer Research ·Junshang Ge, Jie Wang, Fang Xiong, Xianjie Jiang, Kunjie Zhu, Yian Wang, Yongzhen Mo, Zhaojian Gong, Shanshan Zhang, Yi He, Xiayu Li, Lei Shi, Can Guo, Fuyan Wang, Ming Zhou, Bo Xiang, Yong Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng	113
6	The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway 2021 ·Cancer Letters ·Maonan Wang, (unknown), Dan Wang, Ting Tang, Fang Xiong, Bo Xiang, Ming Zhou, Xiaoling Li, Yong Li, Wei Xiong, Guiyuan Li, Zhaoyang Zeng, Can Guo	27
7	Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy 2020 ·Molecular Cancer ·Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, (unknown), Chunwei Li, Jie Wang, Yongzhen Mo, (unknown), Yunhua Chen, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Zhaoyang Zeng, Wei Xiong	218
8	Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation 2020 ·Cancer Cell International ·Lian Gong, (unknown), Dong He, Yuxing Zhu, Liang Xiang, Mengqing Xiao, Ying Bao, Xiaoming Liu, (unknown), Jianye Liu, Ming Zhou, Yanhong Zhou, Yaxin Cheng, Yeyu Zhang, Liping Deng, Rongrong Zhu, (unknown), Ke Cao	9
9	Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape breakdown → 2019 ·Molecular Cancer ·Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Junshang Ge, Bo Xiang, Xu Wu, Jian Ma, Ming Zhou, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong, Can Guo, Zhaoyang Zeng	1064
10	Analysis of status and countermeasures of cancer incidence and mortality in China 2019 ·Science China Life Sciences ·Chunchun Wu, Mengna Li, Hanbing Meng, Yukun Liu, Weihong Niu, Yao Zhou, Ran Zhao, Yumei Duan, Zhaoyang Zeng, Xiaoling Li, Guiyuan Li, Wei Xiong, Ming Zhou	222
11	BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141 2018 ·Journal of Experimental & Clinical Cancer Research ·Yukun Liu, Ran Zhao, (unknown), Mengna Li, Heran Wang, Weihong Niu, Yao Zhou, Yuanzheng Qiu, Songqing Fan, (unknown), Wei Xiong, Yanhong Zhou, Xiaoling Li, (unknown), Guiyuan Li, Ming Zhou	34
12	Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy 2017 ·Clinical Cancer Research ·Qinghai Zeng, Jianye Liu, Peiguo Cao, Jingjing Li, Xiaoming Liu, Xiaojun Fan, Ling Liu, Yan Cheng, Wei Xiong, Jigang Li, Hao Bo, Yuxing Zhu, Fei Yang, Jun Hu, Ming Zhou, Yanhong Zhou, Qiong Zou, Jianda Zhou, Ke Cao	56
13	Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103 2016 ·Cell Death and Disease ·Baoyu He, Wei‐Ming Li, Yingfen Wu, Fang Wei, Zhaojian Gong, Hao Bo, Yumin Wang, Xiayu Li, Bo Xiang, Can Guo, Qianjin Liao, Pan Chen, Xuyu Zu, Ming Zhou, Jian Ma, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng	123
14	ErbB2-intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling 2015 ·Cell Death and Disease ·David Schmitt, Luciana Madeira da Silva, (unknown), (unknown), R Arora, Sungmin Lim, (unknown), Steven McClellan, Joel Andrews, Andrea G. Kahn, Ming Zhou, E. Ahn, Ming Tan	30
15	High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel 2015 ·PLoS ONE ·Yanwei Luo, Xinye Wang, Heran Wang, Yang Xu, Qiuyuan Wen, Songqing Fan, Ran Zhao, (unknown), Jing Yang, Yukun Liu, Xiayu Li, Wei Xiong, Jian Ma, Shuping Peng, Zhaoyang Zeng, Xiaoling Li, Joshua B. Phillips, Guiyuan Li, Ming Tan, Ming Zhou	24
16	miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance 2012 ·Journal of Biological Chemistry ·Zixing Liu, Hao Liu, Shruti Desai, David Schmitt, Ming Zhou, Hung T. Khong, Kristine S. Klos, Steven McClellan, Øystein Fodstad, Ming Tan	48
17	Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas 2008 ·BMC Molecular Biology ·Zuping Zhang, Dan Li, Minghua Wu, Bo Xiang, Li Wang, Ming Zhou, Pan Chen, Xiaoling Li, Shourong Shen, Guiyuan Li	25
18	Cadmium-induced oxidative stress and response of the ascorbate–glutathione cycle in Bechmeria nivea (L.) Gaud 2007 ·Chemosphere ·Yunguo Liu, Xin Wang, Guangming Zeng, Dan Qu, (unknown), Ming Zhou, Liyuan Chai	124
19	BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis 2006 ·Molecular and Cellular Biochemistry ·Ming Zhou, (unknown), Hou‐De Zhou, Huaying Liu, (unknown), Xiaoling Li, Cong Peng, Wei Xiong, Songqing Fan, Jianhong Lu, (unknown), Shourong Shen, Bo Xiang, Guiyuan Li	16
20	[Expression of BRD7-interacting proteins,BRD2 and BRD3, in nasopharyngeal carcinoma tissues]. 2003 ·PubMed ·Ming Zhou, Cong Peng, Xinmin Nie, Bicheng Zhang, Shiguo Zhu, Ying Yu, Xiaoling Li, Guiyuan Li	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact